← Embedded Finance Index 2026

Cherry Technologies

Can a patient-financing platform become the dominant embedded credit layer for elective healthcare by combining near-universal approval rates with a program-manager model that keeps merchant fees structurally below legacy medical credit cards?

Founded2017
HQSan Francisco, CA, USA
Latest roundSeries C
IndustryFintech / Lending
The story

Cherry Technologies launched in 2017 as a patient financing solution for healthcare providers, offering installment payment plans to patients for medical and aesthetic procedures. Rather than building its own bank charter, Cherry operates as a program manager, partnering with regulated lenders (Cross River Bank, and warehouse facility providers like Castlelake) to originate loans while Cherry handles the technology, underwriting workflow, and merchant network. The company has expanded from dental and chiropractic offices into med spas and broader elective healthcare, reaching 60,000+ provider partners and positioning Cherry's approval rate (~80–90%) and low merchant fees as competitive differentiators against incumbents like CareCredit.

Last 12 months
2023-09
Product timeline
2017
Cherry Technologies founded as a healthcare payment plan / patient financing platform.· lending
2022
Cross River Bank extended a $50M credit facility to Cherry and became Cherry's loan origination partner, enabling efficient consumer credit delivery in the medical space.· lending
2023
Castlelake provided warehouse financing to Cherry Technologies to fund new installment loan originations as its practice-partner network expanded.· lending
The stack
4 layers disclosed in Cherry Technologies’s embedded-finance stack
Banking / BaaS
Lead Bank
Lending
in the full report
Sponsor bank
in the full report
Accounting
in the full report
Accounting gap: none
9 more providers across 3 layers, with confidence-scored evidence and source URLs, are in the Embedded Finance Index report.